Atlas Trials

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

Clinical trial NCT02854605 · COMPLETED

Trial details

NCT number
NCT02854605
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nonalcoholic Steatohepatitis (NASH)
Start date
2016-10-26
Primary completion
2018-01-09
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.